Harrow Announces The Issuance Of J-Code For IOPIDINE 1%
16 Apr 2026 //
GLOBENEWSWIRE
Enforcement Report - Week of June 7, 2023
07 Jun 2023 //
FDA
UK marketing authorisations for IOPIDINE fully transferred to Essential Pharma
15 Dec 2022 //
GLOBENEWSWIRE
Harrow Health Acquires U.S. Commercial Rights to Four Branded Eye Drops
20 Dec 2021 //
BUSINESSWIRE

Market Place
Sourcing Support